151 results
Page 2 of 8
424B2
j2q1sgruz abozz
27 Oct 20
Prospectus for primary offering
7:12am
8-K
EX-2.1
qpqtmksr
27 Oct 20
Exact Sciences to Acquire Thrive, Becoming a Leader In Blood-based, Multi-cancer Screening
7:04am
8-K
ng6 px3sll54ohf1lb9z
21 Apr 20
Results of Operations and Financial Condition
4:32pm
8-K
EX-1.1
hru1da 9ccum5
27 Feb 20
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
5:09pm
424B5
tk72tte3ehe
26 Feb 20
Prospectus supplement for primary offering
4:25pm
424B5
ahl3l11svvg yyhtkl
24 Feb 20
Prospectus supplement for primary offering
4:13pm
424B3
b4e78 rdznb
4 Oct 19
Prospectus supplement
4:57pm
S-4/A
y7c2tfm2g
25 Sep 19
Registration of securities issued in business combination transactions (amended)
9:44pm
S-4
EX-99.1
anorbp3v8o4jd
29 Aug 19
Registration of securities issued in business combination transactions
9:48pm